Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

NCT00707382 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

311

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

GENETIC: (1) Genotyping for CYP4502D6 and 2C19 polymorphisms
OTHER: (2) Intense clinical monitoring
OTHER: (3) Control

Sponsor

Gesche Jurgens

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]